PUBLICATIONS · 25704135
Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children's Oncology Group.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Pediatr Blood Cancer
- Publication date
- 2015 Apr
- First author
- Stieglitz E
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Stieglitz E
- type
- Author
- name
- Ward AF
- type
- Author
- name
- Gerbing RB
- type
- Author
- name
- Alonzo TA
- type
- Author
- name
- Arceci RJ
- type
- Author
- name
- Liu YL
- type
- Author
- name
- Emanuel PD
- type
- Author
- name
- Widemann BC
- type
- Author
- name
- Cheng JW
- type
- Author
- name
- Jayaprakash N
- type
- Author
- name
- Balis FM
- type
- Author
- name
- Castleberry RP
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Stieglitz E
- type
- Author
- name
- Ward AF
- type
- Author
- name
- Gerbing RB
- type
- Author
- name
- Alonzo TA
- type
- Author
- name
- Arceci RJ
- type
- Author
- name
- Liu YL
- type
- Author
- name
- Emanuel PD
- type
- Author
- name
- Widemann BC
- type
- Author
- name
- Cheng JW
- type
- Author
- name
- Jayaprakash N
- type
- Author
- name
- Balis FM
- type
- Author
- name
- Castleberry RP
- type
- Author
- bibliography ids
- nci-bib-de6e523db966b5e0e3b51329
- book metadata
- content sha256
- d5767fd27035b9b8dd86c997e2282076178d694480bf3c2792a8fbadfe9e39b9
- document type
- citation
- dois
- 10.1002/pbc.25342
- electronic publication date
- display
- 2014 Dec 8
- precision
- day
- year
- 2014
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:25704135
- immutable id
- pubmed:25704135@d5767fd27035b9b8dd86c997e2282076178d694480bf3c2792a8fbadfe9e39b9
- journal
- abbreviation
- Pediatr Blood Cancer
- issn electronic
- 1545-5017
- issn print
- 1545-5009
- issue
- 4
- name
- Pediatric blood & cancer
- nlm unique id
- 101186624
- pages
- 629-36
- volume
- 62
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 25704135
- provenance
- batch id
- 74265f1b641f04cf2d05
- provider
- NCBI PubMed ESummary
- record sha256
- 172dd77bd1176370604074cef0f3d7a687f741884ed28a1bd78a2c22ed8a01a6
- response sha256
- 193df6bb6d2ac41af73dc445bf8171fe8076a8c8a5e98882a3d6a1ada428b0f0
- retrieved at
- 2026-09-09T23:47:10.134322+00:00
- publication date
- display
- 2015 Apr
- precision
- month
- year
- 2015
- publication types
- Clinical Trial, Phase II
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase II/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children's Oncology Group.
Preserved source evidence · Not medical advice
Triangle